Page last updated: 2024-08-21

malondialdehyde and Connective Tissue Diseases

malondialdehyde has been researched along with Connective Tissue Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calis, M; Duygulu, F; Evereklioglu, C; Karabulut, AB; Turkoz, Y1
Amara, A; Chaugier, C; Conri, C; Constans, J; Dubourg, L; Geffard, M; Leng, B; Pellegrin, JL; Peuchant, E; Sebban, A1
Kudriavtseva, GV; Makarov, SA; Shishkin, VI1

Other Studies

3 other study(ies) available for malondialdehyde and Connective Tissue Diseases

ArticleYear
Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
    Mediators of inflammation, 2004, Volume: 13, Issue:3

    Topics: Connective Tissue Diseases; Erythrocytes; Female; Free Radical Scavengers; Genes, Dominant; Genes, Recessive; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Nitrates; Nitrites; Reference Values; Superoxide Dismutase; Syndrome; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2004
Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.
    Clinical and experimental immunology, 1995, Volume: 101, Issue:2

    Topics: Adult; Aged; Autoantibodies; Connective Tissue Diseases; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Humans; Immunoglobulin M; Male; Malondialdehyde; Middle Aged; Vasculitis

1995
[Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
    Terapevticheskii arkhiv, 1987, Volume: 59, Issue:4

    Topics: Adult; Arthritis, Rheumatoid; Connective Tissue Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Prostaglandins; Scleroderma, Systemic

1987